Dr. Mehra joined Sofinnova in 2007 as a principal, and in 2014 was promoted to general partner. He focuses on working with entrepreneurs to build drug development companies that have the power to improve the lives of patients. Dr. Mehra represents Sofinnova on the boards of Aclaris, Amplyx, Merus and Spark Therapeutics. Prior to joining Sofinnova, he worked at JP Morgan Partners in private equity and venture capital. Before joining the venture community, Dr. Mehra was a consultant for McKinsey & Company’s healthcare practice, advising large pharmaceutical and biotech companies on core strategic issues.
Dr, Mehra received his M.D. from Columbia University’s College of Physicians and Surgeons. He was an Echols Scholar and conducted National Institute of Health sponsored research on the outcomes, mechanisms and pre-clinical development of therapeutic agents for stroke. He graduated Phi Beta Kappa from the University of Virginia with a B.A. in political theory through the government honors program. While in college, he spent three years as a firefighter for the Seminole Trail Fire Department.